Cargando…
Curative effect of endostar combined with oxaliplatin in the treatment of primary hepatic carcinoma and its influence on immune cells
Curative effect and adverse reactions of oxaliplatin combined with endostar in the interventional treatment of primary hepatic carcinoma (PHC) were investigated. A total of 101 PHC patients from October 2012 to December 2014 in The First Affiliated Hospital of Xi'an Jiaotong University were ret...
Autores principales: | Lei, Changjiang, Ren, Defa, Fu, Meixia, Sun, Chuantao, Ren, Hong, Pan, Qingyun, Li, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403513/ https://www.ncbi.nlm.nih.gov/pubmed/30881491 http://dx.doi.org/10.3892/ol.2019.10022 |
Ejemplares similares
-
Results of a randomized and controlled clinical trial evaluating the efficacy and safety of combination therapy with Endostar and S-1 combined with oxaliplatin in advanced gastric cancer
por: Xu, Rong, et al.
Publicado: (2013) -
Synergistic Antitumor Effects of Endostar in Combination with Oxaliplatin via Inhibition of HIF and CXCR4 in the Colorectal Cell Line SW1116
por: Jin, Fengyan, et al.
Publicado: (2012) -
Suitable carriers for encapsulation and distribution of endostar: comparison of endostar-loaded particulate carriers
por: Chen, Weijie, et al.
Publicado: (2011) -
Primary pulmonary arterial sarcoma treated with endostar injection and radiotherapy
por: Xu, Hui, et al.
Publicado: (2020) -
Primary pulmonary arterial sarcoma treated with Endostar injection and radiotherapy
por: Xu, Hui, et al.
Publicado: (2020)